Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis

Clinical trial NCT06742957 · COMPLETED

Trial details

NCT number: NCT06742957
Sponsor: Teva Pharmaceuticals USA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Type Psorisis

Start date: 2024-12-17
Primary completion: 2025-10-07
Enrollment: 560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.